Curaleaf HoldingsFRA:2XW +4.25%46 OCF Margin % is 6.47% as of Mar. 2026, which is 228% above its 10-year median of 1.97. GuruFocus rates FRA:2XW with a GF Score™ of 46/100 and a GF Value™ of €6.56 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, Curaleaf Holdings ranks worse than 51.3% on this metric.
The historical rank and industry rank for Curaleaf Holdings's OCF Margin % or its related term are showing as below:
FRA:2XW'
s OCF Margin % Range Over the Past 10 Years
Min: -42.96 Med: 1.97 Max: 12.26
Current: 9.34
During the past 12 years, the highest OCF Margin % of Curaleaf Holdings was 12.26%. The lowest was -42.96%. And the median was 1.97%.
FRA:2XW's OCF Margin % is ranked worse than 51.3% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs FRA:2XW: 9.34
Curaleaf Holdings OCF Margin % Related Terms
Curaleaf Holdings OCF Margin % Historical Data
* Premium members only.
The historical data trend for Curaleaf Holdings's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaleaf Holdings OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Curaleaf Holdings's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curaleaf Holdings (FRA:2XW) has a OCF Margin % of 6.47% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Curaleaf Holdings and its competitors. This is 228% above median its historical median of 1.97. According to the industry distribution chart, Curaleaf Holdings ranks #492 out of 959 companies in the Drug Manufacturers industry, placing it in the top 51.3%.
Is Curaleaf Holdings' OCF Margin % too high?
Curaleaf Holdings' current OCF Margin % of 6.47% is 228% above median its 10-year median of 1.97. The Drug Manufacturers industry median OCF Margin % is 9.94. Curaleaf Holdings' value of 6.47% is 34.9% below this industry median. Based on the distribution chart, Curaleaf Holdings ranks #492 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Curaleaf Holdings has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #492 out of 959 companies for OCF Margin %. This places Curaleaf Holdings in the lower half of its industry. The industry median OCF Margin % is 9.94. Curaleaf Holdings' value of 6.47% is 34.9% below this benchmark. While the company's 10-year median is 1.97 vs. the industry median of 9.94, Curaleaf Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curaleaf Holdings's current OCF Margin % of 6.47% is 34.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Curaleaf Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current OCF Margin % is 6.47%, which is 228% above median its own 10-year median of 1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (FRA:2XW) is currently considered Modestly Overvalued. The stock's GF Value™ is €6.56, compared to a current price of €8.23 — trading 25.4% above its estimated fair value. The current OCF Margin % is 6.47%, which is 228% above median its 10-year median of 1.97 and 34.9% below the Drug Manufacturers industry median of 9.94. Curaleaf Holdings' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Curaleaf Holdings (FRA:2XW), the current OCF Margin % is 6.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curaleaf Holdings (FRA:2XW) Overvalued in 2026?
Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued.
The current stock price of €8.23 is trading 25.4% above its estimated GF Value™ of €6.56.
GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.
Key valuation signals for FRA:2XW:
OCF Margin %: 6.47% (228% above median its 10-year median of 1.97)
GF Value™: €6.56 vs. price of €8.23 (25.4% above fair value)
Industry Position: 34.9% below the Drug Manufacturers median (#492 of 959)
No single metric tells the full story. See the FRA:2XW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
46GF Score
Get the complete analysis for FRA:2XW
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2XW has been successfully added to your 
